Sunday 11 October 2026 Export all VTR data to Excel Powerpack

Ventas, Inc.

VTR Real Estate Reit Healthcare Facilities

Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024. In the quarter to June 2026, revenue grew 21.7%, EPS fell 6.67%, free cash flow grew 13.6% and total debt fell 2.82%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for five; insiders bought in the last twelve months.

82.04 0.28 +0.34%
Market cap
$42.9B
P/E
149×
Fwd P/E
133×
Dividend yield
2.49%
F-score
7/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Ventas, Inc. (VTR) EV/EBITDA

Alert me on EV/EBITDA

As of 9 October 2026, Ventas, Inc. (VTR) trades at a EV/EBITDA of 21.9×. Over the past ten years it has ranged from 9.5× (March 2020) to 25.7× (July 2026); the current reading is higher than 86% of that period. That is above the Reit Healthcare Facilities industry median of 15.4× and above the Real Estate sector median of 15.0×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 21.3× 10.39%
FY2024 19.3× 1.48%
FY2023 19.0× 3.64%
FY2022 18.3× (10.19%)
FY2021 20.4× 16.96%
FY2020 17.4× 0.99%
FY2019 17.3× 4.11%
FY2018 16.6× 0.00%
FY2017 16.6× (3.83%)
FY2016 17.3× 5.06%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 23.3× 4.76%
Mar 2026 22.2× 4.37%
Dec 2025 21.3× 2.89%
Sep 2025 20.7× 3.20%
42 more quarters

Against its own ten years

Low 9.5× High 25.7×
Ten-year median 18.6×
Current reading's percentile 86

EV/EBITDA against peers

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on VTR